In a business update, Gerresheimer announced that it has gained one large order for inhaler manufacturing in Europe but has lost another because "the customer's inhaler business fell short of its expectations." As a result, the company said, it plans to invest in a manufacturing facility in Horsovsky Tyn, the Czech Republic and will close a plant in Küssnacht, … [Read more...] about Gerresheimer gains one inhaler manufacturing order, loses another
News
Phase 2b study of Oyster Point’s nasal spray for dry eye disease meets primary endpoints
Oyster Point Pharma has announced that the Phase 2b PEARL study of its OC-02 intranasal nicotinic acetylcholine receptor (nAChR) agonist for the treatment of dry eye disease demonstrated a statistically significant increase in production of tear film as well as a statistically significant reduction in symptoms for patients using OC-02 compared to placebo. The … [Read more...] about Phase 2b study of Oyster Point’s nasal spray for dry eye disease meets primary endpoints
Ziccum gets Horizon 2020 grant for dry powder technology
Inhalation Sciences subsidiary Ziccum has been awarded a grant of 500,000 SEK (~ €48,600) by the EU's Horizon 2020 research and innovation project for scale up of its LaminarPace spray drying technology, the company said. A small scale version of LaminarPace is currently in use for creation of dry powder formulations of drugs, vaccines, and biologics. According to … [Read more...] about Ziccum gets Horizon 2020 grant for dry powder technology
TFF Pharmaceuticals announces US patent for DPI particle technology
TFF Pharmaceuticals said that it has received a notice of allowance for US Patent Application No. 12/778,795, titled, "Compositions and Methods of Making Brittle-Matrix Particles Through Blister Pack Freezing," which covers technology related to the company's DPI products for respiratory conditions. Earlier this year, TFF announced that it had raised $14 million … [Read more...] about TFF Pharmaceuticals announces US patent for DPI particle technology
Seqirus gets rights to market Ryaltris nasal spray in Australia and New Zealand
Glenmark Pharmaceuticals has announced that it will receive an unspecified amount up front, plus regulatory and commercial milestone payments, from Seqirus for the rights to commercialize Ryaltris olopatadine hydrochloride/mometasone furoate nasal spray in Australia and New Zealand. In December 2017, Glenmark announced positive results from a Phase 3 trial of … [Read more...] about Seqirus gets rights to market Ryaltris nasal spray in Australia and New Zealand
Senzer announces plans to launch cannabidiol inhalation solution in UK
Senzer Ltd has announced plans to launch several inhaled cannabinoid products in the UK, beginning with its Cannafen cannabidiol inhalation solution later this year. Senzer is a subsidiary of Kind Consumer, whose Voke nicotine inhaler was approved by the MHRA for nicotine cessation in 2014. The company will launch the inhaled cannabinoid product under a specials … [Read more...] about Senzer announces plans to launch cannabidiol inhalation solution in UK
Luz Saúde partners with Amiko Digital Health
Amiko Digital Health has announced that Portuguese health care group Luz Saúde has signed an agreement for the use of Amiko's Respiro inhaler monitoring platform for asthma and COPD management. Earlier this year, Amiko announced that the Respiro platform received the CE mark for use with Spiromax, Nexthaler, and Ellipta inhalers, and the company had received a … [Read more...] about Luz Saúde partners with Amiko Digital Health
Catalent acquires Juniper Pharmaceuticals
Catalent has announced that it will acquire Juniper Pharma Services (formerly Molecular Profiles) along with its parent company Juniper Pharmaceuticals. Catalent will pay $11.50 per share to acquire all of Juniper Pharmaceuticals' stock. Juniper Pharmaceuticals acquired CDMO Molecular Profiles in 2015 and changed its name to Juniper Pharma Services. Juniper has … [Read more...] about Catalent acquires Juniper Pharmaceuticals
Menarini to market Orion DPIs in Asia-Pacific region
Menarini Asia-Pacific Holdings has signed a multi-year licensing agreement with Orion Corporation for distribution and commercialization of Easyhaler DPI products in China, Hong Kong, Philippines, Malaysia, Indonesia, Thailand, Singapore, Vietnam, Taiwan, and South Korea, the companies said. In 2016, Menarini and Orion announced that Menarini would co-market … [Read more...] about Menarini to market Orion DPIs in Asia-Pacific region
Stevanato Group to manufacture and sell Iconovo’s ICOcap inhaler
Swedish DPI developer Iconovo has announced a manufacturing, sales, and distribution agreement with Stevanato Group for its ICOcap dry powder inhaler. The capsule-based ICOcap device will be manufactured by Stevanato Group subsidiary Balda. According to the announcement, Stevanato Group has a sales and marketing presence in more than 150 countries. Iconovo CEO … [Read more...] about Stevanato Group to manufacture and sell Iconovo’s ICOcap inhaler